IN2014CN03123A - - Google Patents
Download PDFInfo
- Publication number
- IN2014CN03123A IN2014CN03123A IN3123CHN2014A IN2014CN03123A IN 2014CN03123 A IN2014CN03123 A IN 2014CN03123A IN 3123CHN2014 A IN3123CHN2014 A IN 3123CHN2014A IN 2014CN03123 A IN2014CN03123 A IN 2014CN03123A
- Authority
- IN
- India
- Prior art keywords
- rebamipide
- medicament
- treatment
- combination
- provides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011240177 | 2011-11-01 | ||
| PCT/JP2012/078769 WO2013065866A1 (en) | 2011-11-01 | 2012-10-31 | A medicament for treating anterior eye disease comprising rebamipide and a tear-retaining agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014CN03123A true IN2014CN03123A (pt) | 2015-07-03 |
Family
ID=47215697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3123CHN2014 IN2014CN03123A (pt) | 2011-11-01 | 2012-10-31 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20140294991A1 (pt) |
| EP (1) | EP2773350A1 (pt) |
| JP (1) | JP6060168B2 (pt) |
| KR (1) | KR101951511B1 (pt) |
| CN (1) | CN103945846A (pt) |
| AR (1) | AR088585A1 (pt) |
| AU (1) | AU2012333448A1 (pt) |
| BR (1) | BR112014010376A2 (pt) |
| CA (1) | CA2851095A1 (pt) |
| CO (1) | CO6960545A2 (pt) |
| EA (1) | EA201490721A1 (pt) |
| HK (1) | HK1198811A1 (pt) |
| IL (1) | IL231922A0 (pt) |
| IN (1) | IN2014CN03123A (pt) |
| MX (1) | MX2014005209A (pt) |
| SG (1) | SG11201401502TA (pt) |
| TW (1) | TW201322982A (pt) |
| WO (1) | WO2013065866A1 (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6081173B2 (ja) * | 2011-12-12 | 2017-02-15 | ロート製薬株式会社 | 眼科用水性組成物 |
| TW201417814A (zh) * | 2012-09-28 | 2014-05-16 | Otsuka Pharma Co Ltd | 包括瑞巴派特之醫藥組成物 |
| JP6267003B2 (ja) * | 2014-02-27 | 2018-01-24 | 参天製薬株式会社 | ジクアホソルまたはその塩およびレバミピドまたはその塩を組み合わせたことを特徴とする涙液分泌促進剤 |
| JP2017052723A (ja) * | 2015-09-10 | 2017-03-16 | 株式会社Ｌｔｔバイオファーマ | ドライアイ改善剤 |
| KR20170039347A (ko) * | 2015-10-01 | 2017-04-11 | 삼진제약주식회사 | 레바미피드를 함유하는 신규한 점안 조성물 및 이의 제조방법 |
| GB201618175D0 (en) * | 2016-10-27 | 2016-12-14 | Warneford Healthcare Ltd | Pharmaceutical compositions |
| KR101840256B1 (ko) * | 2017-09-21 | 2018-03-21 | 대우제약 주식회사 | 레바미피드를 함유하는 새로운 안구건조증 치료용 점안 조성물 및 이의 가용화 및 안정화 방법 |
| KR101923519B1 (ko) | 2018-06-26 | 2019-02-27 | 대우제약 주식회사 | 레바미피드를 함유하는 안구 건조증 치료용 수용성 다회용 점안제 조성물 및 이의 가용화 및 안정화 방법 |
| KR20200019451A (ko) | 2018-08-14 | 2020-02-24 | 대우제약 주식회사 | 레바미피드를 함유하는 안구 건조증 치료용 수용성 다회용 점안제 조성물 및 이의 가용화 및 안정화 방법 |
| KR20210107607A (ko) | 2018-12-26 | 2021-09-01 | 라이온 가부시키가이샤 | 안과용 조성물 |
| TW202320815A (zh) * | 2021-09-30 | 2023-06-01 | 日商樂敦製藥股份有限公司 | 眼科組成物 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6084225A (ja) * | 1983-10-17 | 1985-05-13 | Hiroko Shimizu | 点眼剤 |
| JPH0723317B2 (ja) * | 1988-03-17 | 1995-03-15 | 生化学工業株式会社 | 角膜上皮層障害症治療剤 |
| AR004214A1 (es) * | 1995-10-12 | 1998-11-04 | Otsuka Pharma Co Ltd | Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas |
| JP3093661B2 (ja) * | 1995-10-12 | 2000-10-03 | 大塚製薬株式会社 | 眼疾患治療剤 |
| TWI363626B (en) * | 2004-11-15 | 2012-05-11 | Otsuka Pharma Co Ltd | Aqueous ophthalmic suspension of crystalline rebamipide |
| US8388995B1 (en) * | 2006-02-03 | 2013-03-05 | Auburn University | Controlled and extended delivery of hyaluronic acid and comfort molecules via a contact lens platform |
| TWI415629B (zh) | 2006-10-26 | 2013-11-21 | Otsuka Pharma Co Ltd | 含有瑞巴匹特之水性醫藥懸浮物及其製造方法 |
| CN101534812B (zh) * | 2006-12-11 | 2012-09-05 | 希格马托制药工业公司 | L-卡尼汀制备用于治疗角膜疾病的滴眼剂形式药物的用途 |
| WO2008074853A1 (en) * | 2006-12-21 | 2008-06-26 | Novartis Ag | Ophthalmic rebamipide solution |
| SI2285413T1 (sl) * | 2008-06-19 | 2012-09-28 | Otsuka Pharma Co Ltd | Farmacevtski sestavek |
| US20120003296A1 (en) * | 2010-07-01 | 2012-01-05 | Shantha Totada R | New methods of treating dry eye syndrome |
| US20110021974A1 (en) * | 2010-10-05 | 2011-01-27 | Shantha Totada R | Retinitis pigmentosa treatment and prophalaxis |
| US20110052678A1 (en) * | 2010-11-05 | 2011-03-03 | Shantha Totada R | Method for treating age related macular degeneration |
-
2012
- 2012-10-29 TW TW101139895A patent/TW201322982A/zh unknown
- 2012-10-31 WO PCT/JP2012/078769 patent/WO2013065866A1/en active Application Filing
- 2012-10-31 CN CN201280053483.0A patent/CN103945846A/zh active Pending
- 2012-10-31 KR KR1020147014332A patent/KR101951511B1/ko active IP Right Grant
- 2012-10-31 JP JP2014538080A patent/JP6060168B2/ja active Active
- 2012-10-31 MX MX2014005209A patent/MX2014005209A/es not_active Application Discontinuation
- 2012-10-31 IN IN3123CHN2014 patent/IN2014CN03123A/en unknown
- 2012-10-31 US US14/355,375 patent/US20140294991A1/en not_active Abandoned
- 2012-10-31 AU AU2012333448A patent/AU2012333448A1/en not_active Abandoned
- 2012-10-31 CA CA2851095A patent/CA2851095A1/en not_active Abandoned
- 2012-10-31 BR BR112014010376A patent/BR112014010376A2/pt not_active IP Right Cessation
- 2012-10-31 EA EA201490721A patent/EA201490721A1/ru unknown
- 2012-10-31 SG SG11201401502TA patent/SG11201401502TA/en unknown
- 2012-10-31 AR ARP120104065A patent/AR088585A1/es unknown
- 2012-10-31 EP EP12788303.1A patent/EP2773350A1/en not_active Withdrawn
-
2014
- 2014-04-03 IL IL231922A patent/IL231922A0/en unknown
- 2014-05-14 CO CO14103881A patent/CO6960545A2/es unknown
- 2014-12-05 HK HK14112267.5A patent/HK1198811A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012333448A1 (en) | 2014-05-22 |
| SG11201401502TA (en) | 2014-09-26 |
| TW201322982A (zh) | 2013-06-16 |
| IL231922A0 (en) | 2014-05-28 |
| MX2014005209A (es) | 2014-05-28 |
| BR112014010376A2 (pt) | 2017-04-25 |
| KR101951511B1 (ko) | 2019-02-22 |
| HK1198811A1 (en) | 2015-06-12 |
| KR20140087030A (ko) | 2014-07-08 |
| US20140294991A1 (en) | 2014-10-02 |
| CN103945846A (zh) | 2014-07-23 |
| JP6060168B2 (ja) | 2017-01-11 |
| CO6960545A2 (es) | 2014-05-30 |
| WO2013065866A1 (en) | 2013-05-10 |
| CA2851095A1 (en) | 2013-05-10 |
| EA201490721A1 (ru) | 2014-08-29 |
| EP2773350A1 (en) | 2014-09-10 |
| JP2014532641A (ja) | 2014-12-08 |
| AR088585A1 (es) | 2014-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014CN03123A (pt) | ||
| MY171920A (en) | Prevention and treatment of ocular conditions | |
| NZ704266A (en) | Inhibitors of alpha-crystallin aggregation for the treatment for cataract | |
| HK1203478A1 (en) | Methods for the treatment of diabetic retinopathy and other ophthalmic diseases | |
| HK1205461A1 (en) | Compositions and methods for ocular delivery of a therapeutic agent | |
| EP2838584A4 (en) | EYE IMPLANTS FOR DELIVERY INTO A FRONT EYE CHAMBER | |
| IL227412A (en) | Administration of cross-materials to corne by iontophoresis for the treatment of keratoconus and ophthalmic preparations for this purpose | |
| HK1210968A1 (en) | Compositions and treatment for eye diseases and disorders | |
| MX356525B (es) | Vectores de virus asociados con adeno (aav) para uso en terapia de genes de coroideremia. | |
| MX351464B (es) | El uso de un agonista del receptor 8 tipo toll para el tratamiento de enfermedades alérgicas. | |
| ZA201308617B (en) | Use of thiazolide compounds for the prevention and treatment of viral diseases, cancer and diseases caused by intracellular infections | |
| NZ727304A (en) | Compositions and methods of use of phorbol esters for the treatment of stroke | |
| EP2671586A4 (en) | PHARMACOTHERAPY FOR THE PREVENTION OR TREATMENT OF GLAUCOMA | |
| MX356728B (es) | Combinación farmacéutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2. | |
| WO2012119070A3 (en) | Silicone-based ophthalmic formulations | |
| EP2623494A4 (en) | AGENT FOR THE TREATMENT OF OCULAR DISEASES | |
| HK1200111A1 (en) | Prophylactic, ameliorating or therapeutic agent for retinal diseases | |
| IN2014CN04809A (pt) | ||
| MX2016003293A (es) | Metodos y composiciones para el tratamiento de una infeccion por clamidia y enfermedades y trastornos relacionados. | |
| MX2014000870A (es) | Composiciones farmaceuticas que comprenden 4-bromo-n-(imidazolidin -2-iliden)-1h-benzimidazol-5-amina para tratar enfermedades de la retina. | |
| GB201107576D0 (en) | Novel compounds and methods for use in medicine | |
| MX357828B (es) | Composición con factores de crecimiento destinada al tratamiento intranasal de una enfermedad neurodegenerativa u otra patología del sistema nervioso central, y su método de fabricación. | |
| EP2670421A4 (en) | USE OF ICAM-1 FOR THE PREVENTION OR TREATMENT OF NEUROLOGICAL DISEASES | |
| NZ623275A (en) | Treatment of ocular disease | |
| UA74055U (ru) | Способ хирургического лечения рефрактерных форм глаукомы |